Mueller, R.B.; Hasler, C.; Popp, F.; Mattow, F.; Durmisi, M.; Souza, A.; Hasler, P.; Rubbert-Roth, A.; Schulze-Koops, H.; von Kempis, J.
Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts. J. Clin. Med. 2019, 8, 1548.
https://doi.org/10.3390/jcm8101548
AMA Style
Mueller RB, Hasler C, Popp F, Mattow F, Durmisi M, Souza A, Hasler P, Rubbert-Roth A, Schulze-Koops H, von Kempis J.
Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts. Journal of Clinical Medicine. 2019; 8(10):1548.
https://doi.org/10.3390/jcm8101548
Chicago/Turabian Style
Mueller, Ruediger B., Caroline Hasler, Florian Popp, Frederik Mattow, Mirsada Durmisi, Alexander Souza, Paul Hasler, Andrea Rubbert-Roth, Hendrik Schulze-Koops, and Johannes von Kempis.
2019. "Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts" Journal of Clinical Medicine 8, no. 10: 1548.
https://doi.org/10.3390/jcm8101548
APA Style
Mueller, R. B., Hasler, C., Popp, F., Mattow, F., Durmisi, M., Souza, A., Hasler, P., Rubbert-Roth, A., Schulze-Koops, H., & von Kempis, J.
(2019). Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts. Journal of Clinical Medicine, 8(10), 1548.
https://doi.org/10.3390/jcm8101548